US Asset Management LLC Buys Shares of 2,247 The Clorox Company (NYSE:CLX)

US Asset Management LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 2,247 shares of the company’s stock, valued at approximately $320,000.

Other hedge funds have also modified their holdings of the company. Fortitude Family Office LLC bought a new stake in Clorox during the 4th quarter valued at approximately $29,000. Tyler Stone Wealth Management lifted its holdings in shares of Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Hartford Financial Management Inc. boosted its position in shares of Clorox by 57.1% during the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after acquiring an additional 93 shares during the last quarter. Valley National Advisers Inc. grew its stake in Clorox by 458.3% during the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock valued at $38,000 after acquiring an additional 220 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC bought a new stake in Clorox in the 4th quarter valued at $38,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Up 0.8 %

Shares of NYSE:CLX traded up $1.14 during trading hours on Thursday, hitting $141.56. 799,002 shares of the company’s stock traded hands, compared to its average volume of 1,265,905. The firm has a market capitalization of $17.58 billion, a P/E ratio of 73.35, a price-to-earnings-growth ratio of 2.13 and a beta of 0.44. The business has a fifty day moving average price of $147.74 and a 200-day moving average price of $143.65. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $170.43. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the previous year, the business earned $1.51 EPS. Clorox’s revenue was down 5.3% compared to the same quarter last year. Equities analysts expect that The Clorox Company will post 5.83 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.39%. Clorox’s dividend payout ratio is currently 248.70%.

Analysts Set New Price Targets

CLX has been the subject of a number of research analyst reports. UBS Group cut their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. JPMorgan Chase & Co. reduced their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Evercore ISI lowered their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Citigroup reduced their price target on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Finally, The Goldman Sachs Group started coverage on shares of Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $146.43.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.